A detailed history of Integrated Advisors Network LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Integrated Advisors Network LLC holds 3,753 shares of VRTX stock, worth $1.69 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,753
Previous 3,372 11.3%
Holding current value
$1.69 Million
Previous $1.58 Million 10.44%
% of portfolio
0.08%
Previous 0.08%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$460.0 - $505.78 $175,260 - $192,702
381 Added 11.3%
3,753 $1.75 Million
Q2 2024

Aug 09, 2024

BUY
$392.81 - $485.53 $285,572 - $352,980
727 Added 27.49%
3,372 $1.58 Million
Q1 2024

May 03, 2024

BUY
$407.69 - $446.08 $278,452 - $304,672
683 Added 34.81%
2,645 $1.11 Million
Q4 2023

Feb 26, 2024

BUY
$343.0 - $410.68 $52,479 - $62,834
153 Added 8.46%
1,962 $798,000
Q3 2023

Nov 16, 2023

BUY
$338.18 - $362.46 $3,043 - $3,262
9 Added 0.5%
1,809 $629,000
Q2 2023

Jul 14, 2023

BUY
$314.42 - $351.91 $32,699 - $36,598
104 Added 6.13%
1,800 $633,000
Q1 2023

May 05, 2023

BUY
$283.23 - $323.1 $13,028 - $14,862
46 Added 2.79%
1,696 $534,000
Q4 2022

Feb 02, 2023

BUY
$285.76 - $321.48 $471,504 - $530,442
1,650 New
1,650 $476,000
Q3 2022

Nov 07, 2022

SELL
$273.83 - $305.53 $14,239 - $15,887
-52 Reduced 2.3%
2,212 $640,000
Q2 2022

Aug 12, 2022

SELL
$234.96 - $292.55 $2,114 - $2,632
-9 Reduced 0.4%
2,264 $638,000
Q1 2022

May 02, 2022

BUY
$221.42 - $260.97 $68,640 - $80,900
310 Added 15.79%
2,273 $593,000
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $53,457 - $67,481
302 Added 18.18%
1,963 $431,000
Q3 2021

Nov 15, 2021

BUY
$181.39 - $202.99 $37,729 - $42,221
208 Added 14.32%
1,661 $301,000
Q2 2021

Aug 06, 2021

SELL
$187.49 - $221.1 $191,052 - $225,300
-1,019 Reduced 41.22%
1,453 $293,000
Q1 2021

May 17, 2021

BUY
$207.02 - $241.31 $91,295 - $106,417
441 Added 21.71%
2,472 $531,000
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $58,169 - $77,581
281 Added 16.06%
2,031 $480,000
Q3 2020

Nov 09, 2020

BUY
$255.65 - $303.1 $68,002 - $80,624
266 Added 17.92%
1,750 $476,000
Q2 2020

Aug 13, 2020

BUY
$225.48 - $295.8 $69,673 - $91,402
309 Added 26.3%
1,484 $430,000
Q1 2020

May 06, 2020

BUY
$199.77 - $247.81 $234,729 - $291,176
1,175 New
1,175 $280,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Integrated Advisors Network LLC Portfolio

Follow Integrated Advisors Network LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Advisors Network LLC with notifications on news.